Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines

Radiation Research

Volumn 170, Issue 1, 2008, Pages 41-48

  Bottke, Dirk ^a   Koychev, Daniel ^b,c   Busse, Antonia ^b   Heufelder, Karin ^b   Wiegel, Thomas ^a   Thiel, Eckhard ^b   Hinkelbein, Wolfgang ^b   Keilholz, Ulrich ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; CISPLATIN; DOXORUBICIN; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RADIOTHERAPY; COLON CANCER; FLOW CYTOMETRY; GENE INDUCTION; HUMAN; HUMAN CELL; IRRADIATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASMS; P-GLYCOPROTEIN; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 46449132246     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0986.1     Document Type: Article

References (26)

1. B. T. Hill, Interactions between antitumour agents and radiation and the expression of resistance. Cancer Treat. Rev. 18, 149-190 (1991).
2. I. O. Ng, K. Y. Lam, M. Ng, D. L. Kwong and J. S. Sham, Expression of P-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma. Cancer 83, 851-857 (1998).
3. B. T. Hill, R. D. Whelan, L. K. Hosking, P. Bedford, W. C. Dempke and S. A. Shellard, Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation. Cancer Treat. Rev. 17 (Suppl. A), 21-26 (1990).
4. B. T. Hill, E. Moran, C. Etievant, D. Perrin, A. Masterson, A. Larkin and R. D. Whelan, Low-dose twice-daily fractionated X-irradiation of ovarian tumor cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP1. Anticancer Drugs 11, 193-200 (2000).
5. S. Akashi-Tanaka, T. Fukutomi and H. Tsuda, Higher level of P-glycoprotein expression in human breast cancer cells after radiation therapy. Breast Cancer 2, 99-103 (1995).
6. B. T. Hill, K. Deuchars, L. K. Hosking, V. Ling and R. D. Whelan, Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro. J. Natl. Cancer Inst. 82, 607-612 (1990).
7. J. Mattern, T. Efferth and M. Volm, Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo. Radiat. Res. 127, 335-338 (1991).
8. G. Stammler, E. W. Pommerenke, U. Masanek, J. Mattern and M. Volm, Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation. J. Exp. Ther. Oncol. 1, 39-48 (1996).
9. S. McClean, R. D. Whelan, L. K. Hosking and B. T. Hill, Expression of drug resistance in Chinese hamster ovary (CHO) cells following X-ray pre-treatment in vitro. Biochem. Soc. Trans. 19, 278S (1991). [Abstract]
10. S. McClean, L. K. Hosking and B. T. Hill, Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells. J. Natl. Cancer Inst. 85, 48-53 (1993).
11. D. Nielsen, C. Maare, J. Eriksen, T. Litman and T. Skovsgaard, Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 51, 1050-1057 (2001).
12. S. McClean, R. D. Whelan, L. K. Hosking, G. M. Hodges, F. H. Thompson, M. B. Meyers, G. J. Schuurhuis and B. T. Hill, Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in vitro exposure to fractionated X-irradiation. Biochim. Biophys. Acta 1177, 117-126 (1993).
13. R. M. Harvie, M. W. Davey and R. A. Davey, Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation. Int. J. Cancer 73, 164-167 (1997).
14. S. Henness, M. W. Davey, R. M. Harvie, J. Banyer, V. Wasinger, G. Corthals and R. A. Davey, Changes in gene expression associated with stable drug and radiation resistance in small cell lung cancer cells are similar to those caused by a single X-ray dose. Radiat. Res. 161, 495-503 (2004).
15. S. Henness, M. W. Davey, R. M. Harvie and R. A. Davey, Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIα expression. Int. J. Radiat. Oncol. Biol. Phys. 54, 895-902 (2002).
16. M. H. Mossink, A. van Zon, R. J. Scheper, P. Sonneveld and E. A. Wiemer, Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22, 7458-7467 (2003).
17. A. van Zon, M. H. Mossink, R. J. Scheper, P. Sonneveld and E. A. Wiemer, The vault complex. Cell Mol. Life Sci. 60, 1828-1837 (2003).
18. A. B. Schroeijers, A. C. Siva, G. L. Scheffer, M. C. de Jong, S. C. Bolick, D. F. Dukers, J. W. Slootstra, R. H. Meloen, E. Wiemer and R. J. Scheper, The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res. 60, 1104-1110 (2000).
19. M. Kartalou and J. M. Essigmann, Mechanisms of resistance to cisplatin. Mutat. Res. 478, 23-43 (2001).
20. M. A. Izquierdo, G. L. Scheffer, M. J. Flens, R. H. Shoemaker, L. H. Rome and R. J. Scheper, Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology 19, 191-197 (1996).
21. R. J. Scheper, H. J. Broxterman, G. L. Scheffer, P. Kaaijk, W. S. Dalton, T. H. van Heijningen, C. K. van Kalken, M. L. Slovak, E. G. de Vries and H. M. Pinedo, Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53, 1475-1479 (1993).
22. U. Andersson, K. Grankvist, A. T. Bergenheim, P. Behnam-Motlagh, H. Hedman and R. Henriksson, Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation. Med. Oncol. 19, 1-9 (2002).
23. Z. P. Pavelic, J. Reising, L. Pavelic, D. J. Kelley, P. J. Stambrook and J. L. Gluckman, Detection of P-glycoprotein with four monoclonal antibodies in normal and tumor tissues. Arch. Otolaryngol. Head Neck Surg. 119, 753-757 (1993).
24. D. B. Longley and P. G. Johnston, Molecular mechanisms of drug resistance. J. Pathol. 205, 275-292 (2005).
25. T. Fujita, K. Washio, D. Takabatake, H. Takahashi, S. Yoshitomi, K. Tsukuda, Y. Ishibe, Y. Ogasawara, H. Doihara and N. Shimizu, Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance. Int. J. Cancer 117, 670-682 (2005).
26. W. Berger, U. Setinek, P. Hollaus, T. Zidek, E. Steiner and L. Elbling, Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J. Cancer Res. Clin. Oncol. 131, 355-363 (2005).